Back to Rheumatology


Polymyalgia Rheumatica

Polymyalgia Rheumatica Market Research

What is Polymyalgia Rheumatica (PMR)?

Polymyalgia rheumatica (PMR) is a condition that effects the joints and inflames the muscles, typically causing them to feel stiff and painful. Other symptoms such as fatigue, difficulty sleeping, difficulty moving, depression, and loss of appetite may occur as well. While the cause of the condition remains unknown, physicians note that those diagnosed are typically women over the age of 65. PMR patients may also develop giant cell arteritis (GCA), also known as temporal arteritis, impacting the arteries in the head and neck while ultimately causing more pain in the form of jaw pain, vision problems, and headaches. Treatments for PMR include corticosteroids such as prednisolone, Kevzara (sarilumab), or off-label use of Actemra (tocilizumab). Other treatments include over-the-counter (OTC) pain killers, disease-modifying anti-rheumatic drugs (DMARDs), and treatments to help prevent osteoporosis (which may develop while using steroids).

Spherix Global Insights – Rheumatology – Polymyalgia Rheumatica (PMR)

Spherix Global Insights’ rheumatology therapeutic team is a leading provider of independent syndicated polymyalgia rheumatica market research, insights, business intelligence & advisory services.

Spherix’s rheumatology team publishes two (2) studies in polymyalgia rheumatica including:

  • Market Dynamix™: Polymyalgia Rheumatica (US)
  • Launch Dynamix™: Kevzara (Sanofi/Regeneron) in Polymyalgia Rheumatica (US)

Spherix’s Market Dynamixservice includes analysis of markets anticipated to experience a paradigm shift within the next three to five years. Its insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.

Spherix’s Launch Dynamixservice consists of two parts: monthly KPI tracking and quarterly deep dives. Monthly KPIs provide monthly benchmarking of newly launched products for the first eighteen months of commercial availability, and quarterly deep dive reports covering promotional activity, barriers to uptake, and patient types being identified for the launch brand.

Follow Spherix Rheumatology on Social Media


For Guests & Current Clients

For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here:


Get more information on PMR Coverage